The company’s device uses infrasonic therapy to soothe the body’s nervous system, according to a Sept. 7 news release from Sensate.
“We’re raising from retail investors this time around because we also want our users, supporters, and everyone in between to have access to our upside alongside our institutional investors,” Anna Gudmundson, CEO of Sensate, said in the release.
At the Becker's Fall Behavioral Health Summit, taking place November 4–5 in Chicago, behavioral health leaders and executives will explore strategies for expanding access to care, integrating services, addressing workforce challenges and leveraging innovation to improve outcomes across the behavioral health continuum. Apply for complimentary registration now.
